Is the DLQI appropriate for medical decision-making in psoriasis patients? - Wikidata - awgldk - TriplyDB

Is the DLQI appropriate for medical decision-making in psoriasis patients?

Is the DLQI appropriate for medical decision-making in psoriasis patients?

http://www.wikidata.org/entity/Q48320518

about

A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.

P2860

Q47586627-2A0ECFCB-BAAB-4727-8586-28005E1B7CAA Q52806769-56B54899-8F63-41F1-AF9C-BCF7436ED58C

P2860

Is the DLQI appropriate for medical decision-making in psoriasis patients?

http://www.wikidata.org/entity/Q48320518

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Is the DLQI appropriate for medical decision-making in psoriasis patients?

@en

Is the DLQI appropriate for medical decision-making in psoriasis patients?

@nl

type

label

Is the DLQI appropriate for medical decision-making in psoriasis patients?

@en

Is the DLQI appropriate for medical decision-making in psoriasis patients?

@nl

prefLabel

Is the DLQI appropriate for medical decision-making in psoriasis patients?

@en

Is the DLQI appropriate for medical decision-making in psoriasis patients?

@nl

P1433

Q48320518-FB61A2AA-1620-44FA-8989-E15AE11D1367

P1476

Q48320518-E7226B8A-D541-4BF2-BBAC-6F18DDCDFD45

P2093

Q48320518-091EEE10-ED8E-4417-84B6-8378E40406D2

Q48320518-114F5077-8D4F-4EE6-BEFA-C9FDADC58F63

Q48320518-23B56CF0-938A-4BC8-BBDE-3ACD87D3A298

P2860

Q48320518-02A09348-128F-4162-83D3-357330304BE5

Q48320518-06E30C52-054C-44A1-A62A-23A3570A8C6E

Q48320518-1CD7B859-839B-44C6-BC9D-58BC25DDC4E8

Q48320518-1ECAFD00-D115-4F3C-8757-DFF2CA1B3DEC

Q48320518-20DC68E4-DD09-40A3-AA2F-78119032CC13

Q48320518-24C6B743-DA5C-4FFA-BD43-CC4CC0268A1E

Q48320518-2681BBE8-3885-4314-9BF1-A88808A817AB

Q48320518-30AA83E3-6789-47C1-A288-2F731FF40049

Q48320518-313F653A-1A97-473A-9B3B-A45F9A8BE3F6

Q48320518-3559A768-3AEA-4D34-930F-221D3135ED2D

P2888

Q48320518-0AEFCA9E-7915-4B53-A535-860956D82059

P304

Q48320518-CB7F76D9-216B-4B48-BC22-4F1BF07B645C

P31

Q48320518-7CCCEDA2-DF5C-46C9-BE13-679FBCB158F5

P356

Q48320518-CC950043-4C3B-4155-A134-7EEB038502C9

P433

Q48320518-344A8FE7-A24C-4A95-803A-BA89D63B180D

P478

Q48320518-8AF0AE54-F82F-4B0E-A7BD-1057CE356150

P50

Q48320518-3B53F87A-6E30-47C8-857F-CFE4BA7A02F2

Q48320518-408752B6-15BA-4AB4-91F6-F3B9C108B60C

Q48320518-5F85EE66-9186-43AE-A088-F82EEE009B5C

Q48320518-9B28032C-8FDD-48A9-8A6D-8CC0072E43C6

Q48320518-C4853A94-F23A-42AA-918D-BCC1A62E2BAF

Q48320518-DE74D483-73E7-412C-A14C-F49E7EBA64A2

Q48320518-E661DA56-28BD-4C08-A47E-F21FF008E20A

P577

Q48320518-1D92D03C-99E0-48DB-A3AF-FB1709D87AB6

P698

Q48320518-B902BE63-8D0A-42B9-857F-7BA38441CAE4

P356

S00403-017-1794-4

P1433

Archives of Dermatological Research

P1476

Is the DLQI appropriate for medical decision-making in psoriasis patients?

@en

P2093

Adrienn Katalin Poór

http://www.w3.org/2001/XMLSchema#string

Bernadett Hidvégi

http://www.w3.org/2001/XMLSchema#string

Péter Holló

http://www.w3.org/2001/XMLSchema#string

P2860

Definition of treatment goals for moderate to severe psoriasis: a European consensus

EuroQol--a new facility for the measurement of health-related quality of life

Psoriasis registries worldwide: systematic overview on registry publications.

Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema.

Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data.

Measuring melasma patients' quality of life using willingness to pay and time trade-off methods in Thai population.

The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.

EuroQol: the current state of play.

Measurement of health state utilities for economic appraisal.

Valuation of scleroderma and psoriatic arthritis health states by the general public.

P2888

s00403-017-1794-4

P304

47-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00403-017-1794-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

310

http://www.w3.org/2001/XMLSchema#string

P50

Sarolta Kárpáti

Valentin Brodszky

László Gulácsi

P577

2017-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29128966

http://www.w3.org/2001/XMLSchema#string